6.1.1.11	(E)-3-(3-ethynyl-4-hydroxyphenyl)-1-(2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)phenyl)prop-2-en-1-one	-	194519	
6.1.1.11	2-mercaptoethanol	-	63	
6.1.1.11	3'-dATP	-	2008	
6.1.1.11	4-hydroxyderricin	-	194518	
6.1.1.11	5'-O-[N-(L-Seryl)-sulfamoyl]adenosine	stable analogue of aminoacyl adenylate intermediate	15565	
6.1.1.11	5'-O-[N-(L-Seryl)-sulfamoyl]adenosine	strong	15565	
6.1.1.11	alanine	-	654	
6.1.1.11	cysteine	-	153	
6.1.1.11	diphosphate	-	17	
6.1.1.11	DL-Serine hydroxamate	inhibition constant for Saccharomyces cerevisiae enzyme is 90fold higher than for Escherichia coli enzyme	29972	
6.1.1.11	glycine	-	72	
6.1.1.11	GSSG	about 16% residual activity at 1 mM	330	
6.1.1.11	Mg2+	inhibition by dead-end complex formation between the ternary complex, E-ATP-Ser, and either free Mg2+ or Mg2P2O7	6	
6.1.1.11	additional information	Trypanosoma brucei is highly sensitive to the action of specific selenoprotein inhibitors	2	
6.1.1.11	p-hydroxymercuribenzoate	-	98	
6.1.1.11	Phenylalanyl adenosine 5'-phosphate	-	97005	
6.1.1.11	Poly-arginine	-	94784	
6.1.1.11	SB-217452	-	156116	
6.1.1.11	serinamide	inhibition of methanogenic type seryl-tRNA synthetase, no inhibition of bacterial type seryl-tRNA synthetase	35235	
6.1.1.11	serine hydroxamate	serine analogue	7562	
6.1.1.11	serine hydroxamate	-	7562	
6.1.1.11	serine methyl ester	-	35236	
6.1.1.11	Seryl adenosine 5'-phosphate	-	97146	
6.1.1.11	siRNA	-	772	
6.1.1.11	threonine	-	2764	
6.1.1.11	tRNASer-C-C	weak	98619	
6.1.1.11	tRNASer-C-C-3'dA	weak	98620	
6.1.1.11	tRNASer-C-C-Aoxi	weak	98621	
6.1.1.11	tRNASer-C-C-Foxi-red	weak	98622	
6.1.1.11	tRNASer-I-G-A oxidized with NaIO4	-	98623